<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03149172</url>
  </required_header>
  <id_info>
    <org_study_id>#10963</org_study_id>
    <nct_id>NCT03149172</nct_id>
  </id_info>
  <brief_title>Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials</brief_title>
  <official_title>Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to conduct a interventional prospective clinical trial to&#xD;
      evaluate the efficacy of three different xenografts for ridge preservation by comparing the&#xD;
      quality of newly formed bone using histomorphometric and micro CT analysis.The three&#xD;
      xenograft materials under investigation are Bio-Oss® (bovine derived xenograft), Equimatrix®&#xD;
      (equine derived xenograft), and Endobon® (bovine derived xenograft). There are no prospective&#xD;
      studies comparing the effectiveness of these three materials, Bio-Oss®, Endobon® and&#xD;
      Equimatrix®, when placed in extraction sockets.&#xD;
&#xD;
      Participants will be recruited from patients in the TUSDM clinics that require extraction of&#xD;
      single rooted non-molar tooth and are treatment planned to receive dental implants in the&#xD;
      future. Participants will be randomized to receive one of the three xenograft materials after&#xD;
      tooth extraction. The percentage of newly formed bone and bone density will be compared&#xD;
      between the three materials 4-6 months after ridge preservation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot prospective clinical trial in which histological and micro CT analysis will&#xD;
      be utilized to compare between Endobon®, Equimatrix®, and Bio-Oss®.&#xD;
&#xD;
      Primary aim: Compare the percentage of newly formed bone between Equimatrix®, Bio-Oss® and&#xD;
      Endobon®.&#xD;
&#xD;
      The investigators hypothesize that the mean percentage of newly formed bone from Equimatrix®&#xD;
      will be higher than Bio-Oss® and/or Endobon®.&#xD;
&#xD;
      Secondary aim: Compare the bone density between Equimatrix®, Bio-Oss® and Endobon®.&#xD;
&#xD;
      The investigators hypothesize that the bone density from Equimatrix® will be higher than&#xD;
      Bio-Oss® and/or Endobon®.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 20, 2014</start_date>
  <completion_date type="Actual">December 7, 2016</completion_date>
  <primary_completion_date type="Actual">June 7, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The surgeon and the subject will not be blinded. The evaluation of the core histology will be done by a blinded investigator.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Percent New Bone Formation</measure>
    <time_frame>4-6 months after ridge preservation surgery</time_frame>
    <description>Histomorphometric determination of % new bone formation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Density</measure>
    <time_frame>4-6 months after ridge preservation surgery</time_frame>
    <description>Measured by Micro CT Scanning</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Alveolar Bone Loss</condition>
  <arm_group>
    <arm_group_label>Equimatrix®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Equimatrix® + Mucograft or alternatives</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bio-Oss®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bio-Oss® + Mucograft or alternatives</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endobon®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endobon® + Mucograft or alternatives</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Equimatrix®</intervention_name>
    <description>Ridge preservation bone grafting after tooth extraction</description>
    <arm_group_label>Equimatrix®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bio-Oss®</intervention_name>
    <description>Ridge preservation bone grafting after tooth extraction</description>
    <arm_group_label>Bio-Oss®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endobon®</intervention_name>
    <description>Ridge preservation bone grafting after tooth extraction</description>
    <arm_group_label>Endobon®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non-restorable single rooted tooth in anterior or premolar region&#xD;
&#xD;
          -  Patient previously treatment planned for implant procedure and implant restoration.&#xD;
&#xD;
          -  &gt; 10 mm from maxillary sinus or inferior alveolar canal (IAC)&#xD;
&#xD;
          -  Intact buccal bone (only minor dehiscence or fenestrations (approximately &lt; 50% of&#xD;
             socket depth) can be accepted&#xD;
&#xD;
          -  Non-smokers.&#xD;
&#xD;
          -  Patients treatment planned for extraction and ridge preservation at Tufts University&#xD;
             School of Dental Medicine.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Poor oral hygiene (plaque index&gt;30%).&#xD;
&#xD;
          -  Systemic diseases that affect bone metabolism:&#xD;
&#xD;
             i. Osteoporosis ii. Osteomalacia iii. Hyperthyroidism iv. Hyperparathyroidism v.&#xD;
             Paget's disease&#xD;
&#xD;
          -  Inflammatory and autoimmune diseases of the oral cavity (severe bone loss)&#xD;
             (self-report):&#xD;
&#xD;
             i. Severe chronic periodontitis ii. Aggressive periodontitis iii. Necrotizing&#xD;
             ulcerative periodontitis iv. Crohn's disease v. Multiple sclerosis vi. Rheumatoid&#xD;
             arthritis vii. Systemic lupus erythematosus&#xD;
&#xD;
          -  History of radiation to the head and neck, and /or chemotherapy.&#xD;
&#xD;
          -  Current corticosteroid therapy.&#xD;
&#xD;
          -  History of IV Bisphosphonates therapy or &gt;3 years of oral intake.&#xD;
&#xD;
          -  Infectious diseases such as HIV, tuberculosis, Hepatitis (self-report).&#xD;
&#xD;
          -  Known allergy to research related materials.&#xD;
&#xD;
          -  Self-reported pregnancy or lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong Hur, DDS, DMD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts University School of Dental Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tufts University School of Dental Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>May 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <results_first_submitted>August 11, 2020</results_first_submitted>
  <results_first_submitted_qc>September 1, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 25, 2020</results_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tufts University</investigator_affiliation>
    <investigator_full_name>Yong Hur</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alveolar Bone Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>25 subjects were screened. However, only 21 subjects were enrolled. 4 patients didn't participate the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Equimatrix®</title>
          <description>Equimatrix® + Mucograft or alternatives&#xD;
Equimatrix®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="P2">
          <title>Bio-Oss®</title>
          <description>Bio-Oss® + Mucograft or alternatives&#xD;
Bio-Oss®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="P3">
          <title>Endobon®</title>
          <description>Endobon® + Mucograft or alternatives&#xD;
Endobon®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Equimatrix®</title>
          <description>Equimatrix® + Mucograft or alternatives&#xD;
Equimatrix®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="B2">
          <title>Bio-Oss®</title>
          <description>Bio-Oss® + Mucograft or alternatives&#xD;
Bio-Oss®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="B3">
          <title>Endobon®</title>
          <description>Endobon® + Mucograft or alternatives&#xD;
Endobon®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="6"/>
            <count group_id="B3" value="7"/>
            <count group_id="B4" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.3" spread="8.7"/>
                    <measurement group_id="B2" value="55.2" spread="12.6"/>
                    <measurement group_id="B3" value="53.5" spread="7.1"/>
                    <measurement group_id="B4" value="56.7" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent New Bone Formation</title>
        <description>Histomorphometric determination of % new bone formation</description>
        <time_frame>4-6 months after ridge preservation surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Equimatrix®</title>
            <description>Equimatrix® + Mucograft or alternatives&#xD;
Equimatrix®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
          <group group_id="O2">
            <title>Bio-Oss®</title>
            <description>Bio-Oss® + Mucograft or alternatives&#xD;
Bio-Oss®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
          <group group_id="O3">
            <title>Endobon®</title>
            <description>Endobon® + Mucograft or alternatives&#xD;
Endobon®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
        </group_list>
        <measure>
          <title>Percent New Bone Formation</title>
          <description>Histomorphometric determination of % new bone formation</description>
          <units>percentage of new bone formation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
                <count group_id="O3" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41" spread="30"/>
                    <measurement group_id="O2" value="25" spread="18"/>
                    <measurement group_id="O3" value="26" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bone Density</title>
        <description>Measured by Micro CT Scanning</description>
        <time_frame>4-6 months after ridge preservation surgery</time_frame>
        <population>The micro-CT data was anaylzed as a preliminary outcome of the primary outcome. A total of 10 patient data was used.</population>
        <group_list>
          <group group_id="O1">
            <title>Equimatrix®</title>
            <description>Equimatrix® + Mucograft or alternatives&#xD;
Equimatrix®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
          <group group_id="O2">
            <title>Bio-Oss®</title>
            <description>Bio-Oss® + Mucograft or alternatives&#xD;
Bio-Oss®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
          <group group_id="O3">
            <title>Endobon®</title>
            <description>Endobon® + Mucograft or alternatives&#xD;
Endobon®: Ridge preservation bone grafting after tooth extraction</description>
          </group>
        </group_list>
        <measure>
          <title>Bone Density</title>
          <description>Measured by Micro CT Scanning</description>
          <population>The micro-CT data was anaylzed as a preliminary outcome of the primary outcome. A total of 10 patient data was used.</population>
          <units>percentage of bone volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.6" spread="18.7"/>
                    <measurement group_id="O2" value="23.0" spread="7.9"/>
                    <measurement group_id="O3" value="12.9" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Adverse events were recorded in source documents and on case report forms. All adverse events were recorded, monitored, and reported to the IRB at time of continuing review or at the study's termination. None of the participants had adverse events to report during the study period.</desc>
      <group_list>
        <group group_id="E1">
          <title>Equimatrix®</title>
          <description>Equimatrix® + Mucograft or alternatives&#xD;
Equimatrix®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="E2">
          <title>Bio-Oss®</title>
          <description>Bio-Oss® + Mucograft or alternatives&#xD;
Bio-Oss®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
        <group group_id="E3">
          <title>Endobon®</title>
          <description>Endobon® + Mucograft or alternatives&#xD;
Endobon®: Ridge preservation bone grafting after tooth extraction</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Yong Hur</name_or_title>
      <organization>Tufts University</organization>
      <phone>6176366531</phone>
      <email>Yong.Hur@tufts.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

